演讲嘉宾：

• Peter Andersen, Statens Serum Institut (Denmark)

• 毕利军，中国科学院(中国)

• Pere-Joan Cardona, Institut Germans Trias i Pujol (Spain)

• 陈维政，伊利诺伊大学芝加哥校区医学院/上海巴斯德研究所(美国/中国)

• Tom Evans, Aeras (USA)

• Joel Ernst, NYU Langone Medical Center (USA)

• Helen Fletcher, London School of Hygiene and Tropical Medicine (UK)

• Sarah Fortune, Harvard School of Public Health (USA)

• Willem Hanekom, Bill & Melinda Gates Foundation (USA)

• Mark Hatherill, South African Tuberculosis Vaccine Initiative (South Africa)

• Stefan Kaufmann, Max Planck Institute for Infection Biology (Germany)

• Kei Katsuno, Global Health Innovation Technology Fund (Japan)

• Grace Kiringa, KEMRI/CDC (Kenya)

• Christian Lienhardt, World Health Organization (Switzerland)

• P. Ling Lin, University of Pittsburgh (USA)

• Katrin Mayer-Barber, NIAID/NIH (USA)

• Helen McShane, University of Oxford (UK)

• Olivier Neyrolles, CNRS-University of Toulouse (France)

• Charles Mgone, EDCTP (Netherlands)

• Tom Ottenhoff, Leiden University Medical Center (Netherlands)

• Jiang Pu, Anhui Zhifei Longcom Biopharmaceutical Co.,Ltd (China)

• François Spertini, Centre Hospitalier Universitaire Vaudois (France)

• Soumya Swaminathan, National Institute for Research in Tuberculosis (India)

• Martin Vordermeier, Animal and Plant Health Agency (UK)

• Gerhard Walzl, Stellenbosch University (South Africa)

• Mitchell Warren, AVAC (USA)

• Richard White, London School of Hygiene and Tropical Medicine (UK)

• Miao Xu, National Institutes for Food and Drug Control (China)

• 宇学峰，天津康希诺生物技术有限公司(中国)